000			01789 a2200469 4500
005			20250513143050.0
264		0	_c19980528
008			199805s 0 0 eng d
022			_a0190-9622
024	7		_a10.1016/s0190-9622(98)70486-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aDe Backer, M
245	0	0	_aTwelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. _h[electronic resource]
260			_bJournal of the American Academy of Dermatology _cMay 1998
300			_aS57-63 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntifungal Agents _xadministration & dosage
650	0	4	_aArthrodermataceae _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aItraconazole _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNaphthalenes _xadministration & dosage
650	0	4	_aOnychomycosis _xdrug therapy
650	0	4	_aTerbinafine
650	0	4	_aTreatment Outcome
700	1		_aDe Vroey, C
700	1		_aLesaffre, E
700	1		_aScheys, I
700	1		_aDe Keyser, P
773	0		_tJournal of the American Academy of Dermatology _gvol. 38 _gno. 5 Pt 3 _gp. S57-63
856	4	0	_uhttps://doi.org/10.1016/s0190-9622(98)70486-4 _zAvailable from publisher's website
999			_c9561687 _d9561687